Diffusion-weighted MRI differentiates the Parkinson variant of multiple system atrophy from PD

Neurology

Volumn 58, Issue 4, 2002, Pages 575-580

  Schocke, M F H ^a   Seppi, K ^a   Esterhammer, R ^a   Kremser, C ^a   Jaschke, W ^a   Poewe, W ^a   Wenning, G K ^a,b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN DEGENERATION; BRAIN REGION; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; DISEASE DURATION; GLOBUS PALLIDUS; GRAY MATTER; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSON VARIANT OF MULTIPLE SYSTEM ATROPHY; PARKINSONISM; PONS; PRIORITY JOURNAL; PUTAMEN; RATING SCALE; STRIATE CORTEX; SUBSTANTIA NIGRA; THALAMUS; WHITE MATTER;

EID: 0037176815     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.58.4.575     Document Type: Article

References (40)

1. Multiple system atrophy: A review of 203 pathologically proven cases
2. The motor disorder of multiple system atrophy
3. Clinical features and natural history of multiple system atrophy: An analysis of 100 cases
4. Progression of dysarthria and dysphagia in postmortem-confirmed parkinsonian disorders
5. Fetal neural graft survival
6. Unilateral transplantation of human fetal mesencephalic tissue into the candate nucleus of patients with Parkinson's disease
7. Parkinson's disease: First of two parts
8. Parkinson's disease: Second of two parts
9. Clinical usefulness of magnetic resonance imaging in multiple system atrophy
10. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy
11. Proton magnetic resonance spectroscopy in Parkinson's disease and atypical parkinsonian disorders
12. Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy
13. Recent advances in atypical parkinsonian disorders
14. MR imaging of anisotropically restricted diffusion of water in the nervous system: Technical, anatomic, and pathologic considerations
15. Diffusion MR imaging: Clinical applications
16. Consensus statement on the diagnosis of multiple system atrophy
17. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: A clinicopathological study of 100 cases
18. Differentiation of atypical parkinsonian syndromes with routine MRI
19. Imaging of diffusion and microcirculation with gradient sensitization: Design, strategy, and significance
20. Multiple system atrophy (Shy-Drager syndrome): MR imaging
21. Parkinson plus syndrome: Diagnosis using high field MR imaging of brain iron
22. The combination of hypointense and hyperintense signal changes on T2-weighted magnetic resonance imaging sequences: A specific marker of multiple system atrophy?
23. MR imaging in progressive supranuclear palsy and Shy-Drager syndrome
24. Systematic review of diffusion and perfusion imaging in acute ischemic stroke
25. Loss of connectivity in Alzheimer's disease: An evaluation of white matter tract integrity with colour coded MR diffusion tensor imaging
26. Diffusion tensor imaging can detect and quantify corticospinal tract degeneration after stroke
27. Evaluation of the substantia nigra in patients with Parkinsonian syndrome accomplished using multishot diffusion-weighted MR imaging
28. Neuropathologic features of Parkinson's, Huntington's, and Alzheimer's diseases
29. Neuropathology of Parkinson's disease
30. Post mortem studies in Parkinson's disease: Is it possible to detect brain areas for specific symptoms?
31. Striatonigral degeneration: A clinicopathological study
32. Neuronal cell loss of the striatonigral system in multiple system atrophy
33. The neuropathology and neurochemistry of multiple system atrophy
34. Magnetic resonance imaging in progressive supranuclear palsy and other parkinsonian disorders
35. A study of parkinsonism in multiple system atrophy: Clinical and MRI correlation
36. Nigro-striatal degeneration demonstrated in parkinsonian patients with iodine-123-beta-CIT SPECT: Methods of quantitation
37. Multiple system atrophy: Natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT
38. Magnetic resonance imaging in hereditary and idiopathic ataxia
39. A new semiautomated, three-dimensional technique allowing precise quantification of total and regional cerebellar volume using MRI
40. Diffusion tensor MR imaging of the human brain